Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Rapid Detection of Bacteria in Bodily Fluids
Yeda R&D Co. Ltd Israel flag Israel
Abstract ID: 1572
An automated, rapid, inexpensive and accurate technology for detecting bacterial infection in biofluids, validated for detection of Urinary Tract Infection (UTI).Infectious diseases remain one of the greatest challenges to global...
Contact
Participants
You
Email me a copy of this message
An automated, rapid, inexpensive and accurate technology for detecting bacterial infection in biofluids, validated for detection of Urinary Tract Infection (UTI).Infectious diseases remain one of the greatest challenges to global health. Infections derive commonly from a viral or bacterial source. Diagnosing the infection source is critical, since treating viral infections with antibiotics is ineffective and contributes to the development of antibiotic resistance. Current diagnostic tests take 2-3 days and are highly prone to human error.

Urinary Tract Infection (UTI) is considered to be the most common bacterial infection and poses a significant healthcare burden, affecting about 150 million people worldwide every year. Financially, the estimated global annual cost of UTI is significant, approximately $6 billion. The current technologies employed for UTI diagnostics are slow, expensive and prone to human errors. The Innovative technology is a simple method to test for bacterial infections verified in the lab for efficient detection of UTI.

Conclusion

The technology employs real-time monitoring and computational analysis of non­-isolative liquid bodily fluid cultures, tapping into existing lab infrastructure. It allows for rapid determination of Colony Forming Unit (CFU) value without the need to perform manual colony counting.

Relevance/Opportunity

Please enquire quoting reference 1572 regarding licensing or codevelopment partnerships.
FEATURED
Last Updated May 2015
Technology Type DIAGNOSTIC
Phase of Development PRECLINICAL
CORPORATION